Pavyoma Therapeutics is a Hyderabad-based pharmaceutical company on a mission to make high-quality oncology medicines more accessible. We are building a focused portfolio of cancer treatments, starting with sterile injectables and oral oncology products, under our own brand in India. From there we are expanding into regulated international markets.
Founded by Ranipavithra (Rani) Sabhavat, who has 20+ years of pharmaceutical experience across Australia, the United States and global markets, Pavyoma brings international quality and regulatory standards to every product we make.
Pavyoma Therapeutics develops, registers and markets oncology medicines. Our aim is to make cancer treatment affordable and available, first in India and then worldwide. We address critical gaps in cancer-medicine supply and make sure patients have access to the treatments they need.
Oncology-only focus with international quality standards and Indian affordability. WHO certified products designed for patients first.
One therapy area, deep expertise, and patient-first thinking in every product we develop.
WHO certified products already in hand, with ANDA/NDA filings planned for the USA, Europe, Australia, and more.
20+ years of international pharmaceutical experience across Australia, USA, and global markets.
Planned integrated, solar-powered, zero-liquid-discharge manufacturing campus in Telangana.
Oncology for India and the World — Pavyoma Therapeutics Private Limited
From hospital injectables to outpatient oral therapies — comprehensive cancer care solutions.
Priority launch: Cisplatin, Carboplatin, Oxaliplatin and Etoposide. Essential cancer medicines for Indian hospitals and oncology centres.
We have an exclusive oncology-only focus, bringing 20+ years of global pharmaceutical experience from Australia, the USA and international markets. Our WHO certified products combine international quality standards with Indian affordability.
Pavyoma's commitment to quality and patient access sets them apart. Their oncology focus and international standards give us confidence.
Chief Oncologist, Leading Cancer Hospital
Target International Markets
We are actively seeking distributors, hospital partners, and licensing partners in India, USA, Europe, Australia, Mexico, UAE/GCC and Asian markets.
Cisplatin, Carboplatin, Oxaliplatin, Etoposide — essential oncology medicines for hospitals and cancer centres.
Our upcoming integrated pharmaceutical campus in Telangana will feature solar power generation with battery storage, zero-liquid-discharge effluent treatment, and high-containment manufacturing designed to WHO-GMP, US FDA and EMA standards.
Whether you're a distributor, hospital partner, or international importer, connect with our team to discuss how Pavyoma can support your oncology medicine needs.
Founded on 20+ years of global pharmaceutical experience, we combine international quality standards with Indian affordability. Our WHO certified oncology products are designed to close supply gaps and ensure patients have access to the treatments they need.
